Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joshua J. DeClercq"'
Autor:
George J Leslie, Jianbin Wang, Max W Richardson, Beth S Haggarty, Kevin L Hua, Jennifer Duong, Anthony J Secreto, Andrea P O Jordon, Josephine Romano, Kritika E Kumar, Joshua J DeClercq, Philip D Gregory, Carl H June, Michael J Root, James L Riley, Michael C Holmes, James A Hoxie
Publikováno v:
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Externí odkaz:
https://doaj.org/article/b2848b8f422e4d1cb691aa0474392450
Autor:
Jianbin Wang, Josephine Romano, Beth S. Haggarty, Michael C. Holmes, James A. Hoxie, James L. Riley, Kevin Hua, Kritika E. Kumar, Andrea P. O. Jordon, George J. Leslie, Max W. Richardson, Philip D. Gregory, Anthony Secreto, Carl H. June, Jennifer Duong, Joshua J. DeClercq, Michael J. Root
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347b289557740991009159ff95cf3e72
http://europepmc.org/articles/PMC5113989
http://europepmc.org/articles/PMC5113989
Autor:
Paula M. Cannon, Joshua J. DeClercq, Jianbin Wang, Philip D. Gregory, Colin M. Exline, Samuel B. Hayward, Richard T. Surosky, David A. Shivak, G. Nicholas Llewellyn, Michael C. Holmes, Patrick Li
Publikováno v:
Nature biotechnology
Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell populatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255407628e9aa3377c850dda51a7bdc0
https://pubmed.ncbi.nlm.nih.gov/26551060
https://pubmed.ncbi.nlm.nih.gov/26551060
Autor:
Jianbin Wang, Samuel B. Hayward, Gary Lee, Joshua J. DeClercq, David A. Shivak, Michael C. Holmes, Patrick Li
Publikováno v:
Molecular Therapy. 24:S54
Immunotherapy using gene-modified T cells for adoptive cell transfer is a rapidly expanding field that is currently being tested in early- and late-stage clinical studies, with recent successes seen in the treatment of hematologic malignancies using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bbd4d18bb6c8e78c094e8ece419dd3a
https://doi.org/10.1016/s1525-0016(16)32942-2
https://doi.org/10.1016/s1525-0016(16)32942-2
Autor:
Joshua J. DeClercq, Jianbin Wang, Philip D. Gregory, David A. Shivak, Gary Lee, Samuel B. Hayward, Michael C. Holmes, Patrick Li
Publikováno v:
Nucleic Acids Research
The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectious disease is a rapidly growing field that has shown great promise in recent clinical trials. Nuclease-driven genome editing provides a method in which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265b333561b82aac3dcdae94af32872a
http://europepmc.org/articles/PMC4756813
http://europepmc.org/articles/PMC4756813
Autor:
Lin, Yen-Sheng1,2 (AUTHOR) yen-sheng.lin@utsouthwestern.edu, DeClercq, Joshua J.3 (AUTHOR) dan.ayers@vumc.org, Ayers, Gregory D.3 (AUTHOR), Gilmor, Ruby J.4 (AUTHOR), Collett, Garen1 (AUTHOR) garen.collett@utsouthwestern.edu, Jain, Nitin B.1,2,3,5 (AUTHOR) nitin.jain@utsouthwestern.edu
Publikováno v:
Journal of Clinical Medicine. Jan2024, Vol. 13 Issue 1, p160. 14p.
Publikováno v:
American Journal of Physical Medicine & Rehabilitation; Oct2023, Vol. 102 Issue 10, p855-860, 6p
Autor:
Leslie, George J.1, Haggarty, Beth S.1, Jordon, Andrea P. O.1, Romano, Josephine1, Kumar, Kritika E.1, Hoxie, James A.1, Wang, Jianbin2, Hua, Kevin L.2, Duong, Jennifer2, DeClercq, Joshua J.2, Gregory, Philip D.2, Holmes, Michael C.2, Richardson, Max W.3, Riley, James L.3, Secreto, Anthony J.4, June, Carl H.4, Root, Michael J.5
Publikováno v:
PLoS Pathogens. 11/17/2016, Vol. 12 Issue 11, p1-30. 30p.
Publikováno v:
Clinical Trials Week; 2024, p251-251, 1p
Publikováno v:
Clinical Trials Week; 11/20/2023, p1529-1529, 1p